PBS listings need review: Guild

An urgent review is needed of the de-listing of some medicines which were available on the PBS and now will cost more OTC, says the Guild.The Guild has written to the Pharmaceutical Benefits Advisory Committee (PBAC) addressing its concerns. As part of the 6CPA ,the Guild agreed to the de-listing of selected OTC products from the PBS on the